A patient diagnosed with small bowel obstruction (SBO) develops sudden severe abdominal pain and a rigid abdomen. What is the nurse's priority action?

Rationale:

A. Carafate (sucralfate) does not neutralize gastric acid. Unlike antacids, it does not chemically alter the pH of the stomach. While antacids temporarily reduce acid and provide symptomatic relief, sucralfate’s action is protective rather than neutralizing, focusing on shielding the ulcer from the harmful effects of acid, pepsin, and bile salts.

B. Carafate does not enhance gastric emptying or affect gastrointestinal motility. Prokinetic agents, such as metoclopramide, are used to increase gastric emptying and prevent reflux, but sucralfate’s mechanism is local mucosal protection, not altering the rate at which food or secretions move through the GI tract.

C. Carafate does not inhibit proton pumps or reduce gastric acid production systemically. Proton pump inhibitors (PPIs), like omeprazole, block the hydrogen-potassium ATPase enzyme in gastric parietal cells to suppress acid secretion. Sucralfate’s mechanism is mechanical and local, forming a protective barrier over the ulcer site rather than decreasing acid production.

D. Sucralfate forms a protective barrier over the ulcer site, binding to exposed proteins in the ulcer base to create a viscous, adhesive coating. This protective layer shields the ulcer from gastric acid, digestive enzymes, and bile salts, allowing the mucosal tissue to heal naturally while reducing pain and irritation. This barrier remains intact for several hours, making timing of administration important.

Rationale:

A. Establishing two large-bore IV lines is the immediate priority for a patient presenting with hematemesis and hypotension, which are classic signs of an acute upper gastrointestinal bleed with hypovolemic shock. Rapid IV access allows for aggressive fluid resuscitation, administration of blood products, and emergency medications. According to emergency and critical care principles (ABCs and circulation first), restoring intravascular volume is essential to maintain tissue perfusion and prevent organ failure.

B. The Trendelenburg position is not recommended for patients with active GI bleeding. It does not reliably improve cerebral perfusion and may increase the risk of aspiration, especially in a patient with hematemesis. Elevating the legs slightly or keeping the patient supine is safer if positioning is needed while resuscitation is initiated.

C. Oral proton pump inhibitors are not appropriate in the acute setting for a patient with active hematemesis and hypotension. The patient is at high risk for aspiration, and oral medications may not be absorbed effectively during shock. IV PPIs may be administered later after hemodynamic stabilization, but they are not the immediate priority.

D. Providing ice chips is contraindicated in a patient with active upper GI bleeding and hypotension. The patient should be kept NPO in anticipation of possible endoscopy or surgery, and oral intake increases the risk of aspiration and does not address the life-threatening problem of volume loss.